Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William K Oh

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
Cancer Investigation|August 7, 2003
Predicting outcome in localized prostate cancer: how far have we come?William K Oh
Clinical Prostate Cancer|March 30, 2004
The evolving role of estrogen therapy in prostate cancerWilliam K Oh
The Journal of Urology|November 13, 2004
An overview of chemotherapy trials in localized and recurrent nonmetastatic prostate cancerWilliam K Oh
The Oncologist|November 8, 2005
High-risk localized prostate cancer: integrating chemotherapyWilliam K Oh
Urologic Oncology|June 18, 2003
Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpointsWilliam K Oh
The Journal of Urology|November 12, 2003
The evolving role of chemotherapy and other systemic therapies for managing localized prostate cancerWilliam K Oh
Urology|September 17, 2002
Secondary hormonal therapies in the treatment of prostate cancerWilliam K OH
Clinical Advances in Hematology & Oncology : H&O|May 17, 2022
Clinical observations regarding the use of androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancerWilliam K Oh
JAMA Oncology|May 13, 2022
Does Circulating Tumor DNA Measure Up to Prostate-Specific Antigen?Tomi Jun, William K Oh
Therapeutic Advances in Medical Oncology|July 27, 2011
Castration-resistant prostate cancer: new science and therapeutic prospectsJoaquim Bellmunt, William K Oh
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Cancer Investigation|August 7, 2003
Predicting outcome in localized prostate cancer: how far have we come?William K Oh
Clinical Prostate Cancer|March 30, 2004
The evolving role of estrogen therapy in prostate cancerWilliam K Oh
The Journal of Urology|November 13, 2004
An overview of chemotherapy trials in localized and recurrent nonmetastatic prostate cancerWilliam K Oh
The Oncologist|November 8, 2005
High-risk localized prostate cancer: integrating chemotherapyWilliam K Oh
Urologic Oncology|June 18, 2003
Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpointsWilliam K Oh
The Journal of Urology|November 12, 2003
The evolving role of chemotherapy and other systemic therapies for managing localized prostate cancerWilliam K Oh
Urology|September 17, 2002
Secondary hormonal therapies in the treatment of prostate cancerWilliam K OH
Clinical Advances in Hematology & Oncology : H&O|May 17, 2022
Clinical observations regarding the use of androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancerWilliam K Oh
JAMA Oncology|May 13, 2022
Does Circulating Tumor DNA Measure Up to Prostate-Specific Antigen?Tomi Jun, William K Oh
Therapeutic Advances in Medical Oncology|July 27, 2011
Castration-resistant prostate cancer: new science and therapeutic prospectsJoaquim Bellmunt, William K Oh
Pageof 27